×
About 8,236 results

ALLMedicine™ Angioedema Center

Research & Reviews  3,469 results

Angioedema with severe acute abdominal pain: Think of hereditary angioedema.
https://doi.org/10.1016/j.clinre.2021.101702
Clinics and Research in Hepatology and Gastroenterology; Mumneh N, Tick M et. al.

Apr 17th, 2021 - Angioedema can be either mast cell- (histamine-) mediated or bradykinin-mediated. Treatment approaches for the two types are very different, making differential diagnosis critical. Severe acute abdominal pain caused by intestinal angioedema is com...

Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema.
https://doi.org/10.2217/pgs-2021-0036
Pharmacogenomics Pall AH, Rasmussen ER et. al.

Apr 14th, 2021 - Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema.|2021|Pall AH,Rasmussen ER,Wadelius M,|

Iodine Contrast Complex Rash Responding to Topical Steroids: A Case Report.
https://doi.org/10.12659/AJCR.928930
The American Journal of Case Reports; El Hussein M, Hamieh C et. al.

Apr 7th, 2021 - BACKGROUND Iodine contrast allergy can cause acute and delayed allergic reactions. Just like any other sensitivity reaction, the severity can vary from mild to moderate skin manifestations such as erythematous rash to an even more severe presentat...

Analysis of Heart-Rate Variability during Angioedema Attacks in Patients with Hereditar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002127
International Journal of Environmental Research and Publi... Perego F, De Maria B et. al.

Apr 3rd, 2021 - C1-inhibitor hereditary angioedema (C1-INH-HAE) is a rare disease characterized by self-limiting edema associated with localized vasodilation due to increased levels of circulating bradykinin. C1-INH-HAE directly influences patients' everyday live...

see more →

Guidelines  19 results

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2...
https://doi.org/10.1111/all.13384
Allergy Maurer M, Magerl M et. al.

Jan 10th, 2018 - Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. I...

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the Britis... Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

A consensus parameter for the evaluation and management of angioedema in the emergency ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100605
Academic Emergency Medicine : Official Journal of the Soc... Moellman JJ, Bernstein JA et. al.

Apr 15th, 2014 - Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioed...

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, an...
https://doi.org/10.1016/j.jaci.2013.03.034
The Journal of Allergy and Clinical Immunology; Zuraw BL, Bernstein JA et. al.

Jun 3rd, 2013 - These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council ...

see more →

Drugs  437 results see all →

Clinicaltrials.gov  4,065 results

Promethazine hydrochloride - promethazine hydrochloride tablet-McKesson Corporation dba SKY Packaging
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=818a4d9a-c8a2-476c-b70c-0840b6d603a1

Apr 18th, 2021 - Promethazine hydrochloride is useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amel...

Icatibant - icatibant acetate injection, solution-Apotex Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39ecd008-37af-4105-84a0-c0cb98b8d0ec

Apr 18th, 2021 - Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. Icatibant injection is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of heredita...

Angioedema with severe acute abdominal pain: Think of hereditary angioedema.
https://doi.org/10.1016/j.clinre.2021.101702
Clinics and Research in Hepatology and Gastroenterology; Mumneh N, Tick M et. al.

Apr 17th, 2021 - Angioedema can be either mast cell- (histamine-) mediated or bradykinin-mediated. Treatment approaches for the two types are very different, making differential diagnosis critical. Severe acute abdominal pain caused by intestinal angioedema is com...

Promethazine hydrochloride - promethazine hydrochloride tablet-Lake Erie Medical DBA Quality Care Products LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=004c4371-e4dc-4d79-8b05-aa2efea49043

Apr 15th, 2021 - Promethazine hydrochloride tablets, USP are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and an...

Promethazine hydrochloride - promethazine hydrochloride syrup-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd6bfddd-df04-439d-909b-609d7b3ba121

Apr 15th, 2021 - Promethazine is useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of al...

see more →

News  237 results

FDA Approvals, Highlights, and Summaries
https://reference.medscape.com/viewarticle/945186

Feb 23rd, 2021 - Allergy/Immunology Orladeyo (berotralstat) Berotralstat is the first oral kallikrein inhibitor approved for prophylaxis of hereditary angioedema (HAE) attacks in patients aged 12 years and older. Kallikrein is a protease that cleaves high-molecula...

Fast Five Quiz: Food Allergies
https://reference.staging.medscape.com/viewarticle/936716_3

Sep 7th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...

Recurrent Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Refractory to Fresh Frozen Plasma
https://www.mdedge.com/fedprac/article/213630/hospital-medicine/recurrent-angiotensin-converting-enzyme-inhibitor-induced/page/0/1?channel=327

Dec 5th, 2019 - Discussion The standard therapy for ACEI-inducedangioedema continues to be airway management and discontinuation of medication. However, life-threatening progression of symptoms have led to the use of off-label therapies, including FFP and bradyki.

FDA Drug Approvals: Pediatrics — Year in Review 2018
https://reference.medscape.com/viewarticle/907375

Jan 14th, 2019 - New Antimicrobials New tetracyclines and antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more New Drugs in Oncology and Hematology Include a wide range of targeted therapies and first-in-class agents New Drugs in Immunology Ne...

HAE Attacks Cut With Lanadelumab
https://www.medpagetoday.com/rheumatology/generalrheumatology/76622

Nov 30th, 2018 - Action Points Patients with type I or type II hereditary angioedema (HAE) suffer from regular, unpredictable and life-disrupting attacks, and patients are in need of better drugs to control this lifelong disabling condition. Patients whose HAE is ...

see more →

Patient Education  9 results see all →